Dental Practice Retirement: Make Your Practice Sale Count

Key Takeaways for Dental Practice Owners

• Your practice sale can be the central financial event in your retirement plan and often represents your largest personal asset.

• Starting formal transition planning 5–10 years before your ideal exit, with financial cleanup and operational upgrades, can raise your eventual sale price.

• Most owners choose between 2 main exit paths: a private doctor-to-doctor sale or a DSO affiliation, and each path can create very different results.

• Experienced sell-side advisors can create competitive tension among vetted buyers, often generating around 10 offers and a valuation premium over selling alone.

• McLerran & Associates supports both exit paths; request a confidential discovery conversation to see how your practice fits into your retirement plan.

The 5–10 Year Retirement Timeline for Your Practice

Owners who begin structured transition planning 3–10 years before their target exit can often realize higher values than those who wait. Early planning focuses on financial normalization and operational improvements that make the practice more attractive to buyers. The table below outlines key milestones across that window.

Years Out	Focus Area	Key Actions	Why It Matters
8–10 Years	Baseline & Strategy	Commission a CPA-led practice valuation, identify your transition path (doctor-to-doctor or DSO), begin EBITDA normalization, which means separating personal and discretionary expenses from true practice profit	Establishes a financial baseline and clarifies which path may serve you best, while starting later than 3 years out can reduce the achievable value
5–7 Years	Value Building	Grow associate production to reduce owner dependence, strengthen hygiene recall rates, review and extend lease to at least 10 years remaining, maximize retirement plan contributions (SEP-IRA, 401(k), defined benefit plans)	High owner dependence, where the selling doctor performs most production, can create a valuation discount, while hygiene recall above 85% can add meaningful enterprise value
3–4 Years	Documentation & Team Assembly	Assemble your advisory team (dental CPA, dental transition attorney, sell-side advisor), document operational systems and SOPs, compile 3 years of clean financials, address deferred equipment maintenance	A practice with documented systems and a trained team can command a goodwill premium over owner-dependent practices
1–2 Years	Pre-Market Preparation	Obtain an updated formal valuation, build a data room (tax returns, production reports by provider, lease documents, staff roster), resolve open regulatory or payer audit issues, lock in associate retention contracts	Buyers closely review every number, so a diligence-grade valuation done up front can help prevent downward price changes during due diligence
6–12 Months	Go to Market	Engage a sell-side advisor to run a structured, competitive bid process, receive and compare offers, negotiate the LOI (letter of intent, which is the term sheet that sets price and structure before final contracts), close	A marketed, competitive process can add a significant premium, and practices taken to market through a structured multiple-buyer process have received final values averaging 50% above initial unsolicited offers

Comparing Doctor-to-Doctor Sales and DSO Affiliations

Most owners of premier practices choose between 2 primary exit paths: a private doctor-to-doctor sale or a DSO or private equity-backed platform affiliation. These paths can create very different results for valuation, cash at close, your post-sale role, and how your legacy is handled.

Dimension	Doctor-to-Doctor (Private Buyer)	DSO / Private Equity Affiliation
Valuation Approach	Typically priced as a percentage of annual collections or a multiple of SDE (Seller’s Discretionary Earnings, which is the practice’s true cash profit available to the owner); private buyers commonly value practices at 65–85% of annual collections	Priced on a multiple of normalized EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization, which is a standardized measure of operating profit after replacing owner compensation with a market-rate associate salary); DSO-eligible transactions can reach 7–12x EBITDA depending on scale and platform fit
Cash at Close	Private buyer dental practice transactions often involve 10–25% seller financing instead of 100% cash at closing	DSO transactions often close with 60–75% cash at close, 15–30% rollover equity, and 5–15% earnout, and as much as 40% of the deal can be paid in DSO equity instead of cash
Post-Sale Role	Doctor-to-doctor sales usually involve 6–24 months of seller transition assistance, and a partnership or vest-out structure can extend this over several years	DSOs are increasingly requiring a minimum 5-year post-close employment term from sellers because of provider risk and clinical continuity needs
Legacy Fit	Legacy preservation is usually high, since the incoming dentist often maintains the practice’s brand, culture, and patient relationships	Legacy fit varies and depends on the DSO’s operating model, because some preserve culture and staff while others may not

The valuation gap between these 2 paths can be meaningful. A $2M revenue practice with $400K EBITDA can be valued at $1.3M–$1.7M to a private buyer versus $2.4M–$2.8M to a DSO buyer, which illustrates a potential 40–80% DSO premium for practices that fit platform criteria. That premium can disappear for practices below roughly $1.2M in collections, heavily owner-dependent practices, rural or non-metropolitan locations, and specialties outside a buyer’s existing clinical mix, based on broker aggregate data from completed 2024–2026 transactions.

Because McLerran & Associates works both paths in roughly equal measure, the firm can provide a side-by-side valuation so owners choose their path with more complete information instead of a guess.

Create Competition Among Qualified Buyers

A practice owner usually sells once in a career, while DSOs negotiate deals every week. That imbalance in experience can be a central challenge in dental practice transitions, and professional sell-side representation can help address it.

Without a structured process, an unrepresented dentist who negotiates with a single DSO has no competitive tension to push the price higher and no clear way to know whether that offer reflects the broader market. Do-it-yourself close rates can run as low as 15–20%, compared with roughly 80% for a well-run brokered process.

McLerran & Associates runs a structured, auction-style bid process that usually lasts 45–60 days and generates around 10 offers from a vetted pool of qualified buyers. Clients often realize the valuation premium mentioned earlier, and the firm reports a transaction rate of roughly 85–90%, compared with an industry norm closer to 35–40%.

The quality of the valuation that supports that process can matter as much as the competition itself. A free, informal number set by a buyer can become the quiet anchor that determines what the owner receives. McLerran’s CPA-led EBITDA analysis is diligence-grade work completed before going to market, and every add-back, such as excess owner compensation, personal vehicle costs, or one-time equipment purchases, is unpacked and documented. Buyers can then scrutinize the numbers without easily pushing the price down during due diligence.

Protect Your Legacy With the Right Buyer Fit

The highest offer does not always represent the right buyer. Owners who have spent decades building a premier practice often care deeply about their patients, staff, and clinical legacy after they step away.

Buyer vetting is a core part of McLerran & Associates’ role. Roughly 130 PE-backed DSOs operate in the U.S., and they vary widely in quality. Some are well-capitalized and well-managed, with a history of satisfied sellers. Others grew quickly when capital flooded the space after COVID and have since struggled, as seen when Dental Care Alliance completed a June 2026 restructuring that eliminated more than $1.1 billion in funded debt, and when Blackstone and KKR assumed control of Affordable Care by reducing roughly 70% of its $1.4 billion private-credit debt load. Partnering with an undercapitalized DSO can place a large share of retained equity at risk.

McLerran & Associates evaluates buyers like investments by reviewing profitability, growth trajectory, management strength, and financial backing, and the firm has blacklisted DSOs known for poor post-close environments so those buyers never reach the table.

For doctor-to-doctor sales, fit often comes from access to a large, premier private-buyer pool that includes thousands of pre-qualified individual buyers and relationships across study clubs, banks, and dental organizations. The goal is an at- or above-ask offer from a qualified buyer who will preserve the practice’s goodwill.

Maximize Value, Structure, and Taxes on Your Sale

Maximizing the outcome of a dental practice sale usually depends on 3 connected areas: valuation, deal structure, and tax planning.

Valuation. The basic DSO formula is Practice Value = Adjusted EBITDA × Market Multiple, yet the inputs often require expert work. Accurate Adjusted EBITDA requires reviewing 3 years of P&L statements, tax returns, year-to-date P&L, and owner W-2s or distributions to identify add-backs. Properly identifying add-backs and running a competitive process can materially increase the sale price. McLerran’s CPA-led analysis helps control the narrative around EBITDA so that number is more likely to hold through due diligence.

Deal structure. DSO offers can be complex. Cash, rollover equity, which is an ownership stake retained in the acquiring DSO platform, and earnouts, which are contingent payments tied to post-close performance, each behave differently over time. Equity can sit at the joint-venture level, which typically provides distributions and a higher floor, or at the holding-company level, which usually provides no distributions but can offer a higher ceiling if the platform later sells at a strong multiple. McLerran prepares multi-year, multi-structure financial forecasts across 3-, 5-, 7-, and 10-year horizons so owners compare real after-tax cash across structures instead of only headline prices.

Tax planning. Goodwill in a U.S. dental practice sale is taxed at long-term capital gains rates of 15–23.8%, including the 3.8% Net Investment Income Tax for high earners, while depreciation recapture on equipment is taxed as ordinary income at rates up to 37%. The allocation of purchase price between personal goodwill and other asset classes, which is negotiated in the purchase agreement, can create meaningful after-tax differences. A CPA with dental transaction experience, rather than a generalist, can be especially helpful for this allocation. Tax planning often works best when it begins 2–3 years before the sale, instead of after a letter of intent is signed.

Owners can also benefit from avoiding overreliance on a single asset such as the practice for retirement income. Building diversified investment accounts outside the practice can create flexibility in sale timing and give you more room to walk away from offers that do not meet your goals. In parallel, maximizing contributions to defined benefit plans, 401(k)s, or cash balance plans in the years before a sale can reduce taxable income in the sale year and support retirement funding.

Build a Dental-Specific Advisory Team

A dental practice sale is usually not a transaction to navigate with a generalist team. Successful transitions often rely on a team that includes a dental-specific CPA, a transition attorney, a practice broker, and a comprehensive financial advisor.

McLerran & Associates works only on the sell side, so the client is always the practice owner. The team brings more than 100 years of combined dental-industry experience as former investment bankers, practice-finance lenders, DSO buyers, CPAs, and advisors. With approximately 2,000 successful practice sales, roughly $2 billion in closed transaction volume, and more than 10,000 practices evaluated, the firm offers market knowledge that a local generalist broker or multi-vertical advisor may not match.

Because McLerran & Associates runs both transition pathways in roughly equal measure, the firm can prepare a true side-by-side valuation that quantifies the practice’s worth in both the private-buyer and DSO markets. Owners can then choose the path that appears to serve them best, instead of relying on a single-lane broker who knows only one or two DSOs.

McLerran & Associates has national reach, with offices in Cleveland (led by Justin Klingshim), Atlanta (led by Matt Sutton), Northern Virginia (led by Andrew Kobylski), Los Angeles (led by Steven Au), and Phoenix (led by Brian Carroll, covering the Mountain West).

Request a confidential discovery call with McLerran & Associates to discuss your practice, your goals, and which transition path may fit you best.

Frequently Asked Questions

Why should I pay for a valuation when other firms offer one for free?

A free valuation often functions as a lead-generation tool, not a number designed to withstand buyer due diligence. When a buyer’s team reviews the financials and finds that add-backs were not documented or EBITDA was overstated, the buyer may push the price down. That renegotiation can cost far more than a professional valuation fee. McLerran & Associates builds a CPA-led, diligence-grade EBITDA analysis up front, and every add-back is unpacked and defensible before the practice goes to market. In one case, a free valuation estimated a practice at $2.5M, while McLerran valued it at $4.5M and it sold for $5.25M after a competitive process. The valuation can function less as a cost and more as the foundation of the outcome.

What multiple will my practice sell for?

Multiples are usually driven by fundamentals rather than a fixed table. Two structural variables that can shape the multiple are practice size, measured by EBITDA, and buyer type. A solo, owner-dependent general practice selling to an individual dentist can be valued very differently from a multi-location, associate-led group selling to a PE-backed DSO platform. Specialty can also matter, because oral and maxillofacial surgery, orthodontics, and pediatric dentistry may command different ranges than general dentistry, depending on the practice’s specific characteristics. Hygiene production as a percentage of collections, payer mix, growth trajectory, provider concentration, and lease terms can all move the multiple within its range. Your multiple usually comes from your numbers and your market, which is what a proper valuation is designed to quantify.

How do I know which DSOs are the good ones?

DSO vetting can be one of the most important and most overlooked parts of the sale process. Of the roughly 130 PE-backed DSOs in the U.S., financial health, management quality, and post-close treatment of affiliated practices can vary widely. Some are well-capitalized and have a strong record of satisfied sellers. Others grew during the post-COVID capital surge and later faced financial pressure, which can place sellers’ retained equity at risk. McLerran & Associates evaluates buyers like investments by reviewing profitability, revenue growth at existing locations, management experience, and the private equity sponsor’s track record. The firm has blacklisted DSOs known for poor post-close environments, so owners see a pool of pre-vetted, well-backed buyers instead of having to review the entire market alone.

Do I have to keep working after I sell?

Your ongoing role usually depends on the chosen path. In a doctor-to-doctor walk-away sale, the seller often works back only 4–8 weeks before exiting, which creates a clean break. In a partnership or vest-out structure, the timeline extends as the incoming dentist buys in over time. In a DSO affiliation, a post-close employment commitment is standard, and DSOs are increasingly requesting a minimum 5-year working agreement from sellers because of provider risk and clinical continuity, although specific terms are negotiable and depend on associate coverage and your clinical role at the time of sale. McLerran & Associates negotiates all aspects of the letter of intent on the owner’s behalf, including earnout structures and employment terms that reflect the seller’s situation.

Is now a good time to sell?

Demand for premier, Class A practices remains strong, and valuations for well-performing practices sit near historically high levels. At the same time, the market has normalized from the 2021–2022 peak, and buyers are conducting more thorough due diligence while deal structures evolve. The window for favorable pricing may not stay open indefinitely. Expiring tax provisions are also creating urgency for some sellers who want to transact before potential rate changes. The right timing for any owner usually depends on that practice’s positioning, financials, and personal goals. McLerran & Associates can provide a candid assessment of how your practice fits into the current market, and if you are not ready to sell, the firm will update your valuation for free a year later instead of pushing you into a premature deal.

Next Steps for Your Dental Practice Transition

Your dental practice is likely the largest single asset in your retirement plan. Treating its sale as the central pillar of that plan, and starting 5–10 years out with dental-specific sell-side representation, can become one of the most consequential financial decisions of your career. The difference between selling alone and working with an advisor who controls the EBITDA story, creates competition among vetted buyers, and defends your valuation through closing can amount to a significant difference in after-tax proceeds.

McLerran & Associates has guided approximately 2,000 owners through this process over roughly 35 years. The firm does more than list practices, and it sells them at the high transaction rate noted earlier, with clients often realizing the valuation premium discussed above compared with selling on their own.

Three ways to move forward:

• Start the conversation now. Schedule a confidential discovery call with McLerran & Associates to discuss your practice, your goals, and your options, whether a transition is 1 year away or 10. Call (512) 900-7989 or email info@dentaltransitions.com.

• Clarify what your practice is worth. Request a comprehensive, CPA-led practice valuation that quantifies your value in both the private-buyer and DSO markets and gives you a defensible number before any buyer conversations begin.

• Educate yourself before deciding. If you are still weighing whether or when to sell, consider attending the McLerran M&A Summit on October 29–30, 2026. Designed for owners who are evaluating their options, the Summit includes expert presentations, one-on-one CPA sessions, 4 CE credits, and a complimentary practice valuation (a $2,500 value) for attendees.